Identillect Reports Continued Positive Subscriber Growth
Aug 30, 2017 11:30 am UTC| Business
IRVINE, Calif., Aug. 30, 2017 -- Identillect Technologies Corp. (the "Company" or "Identillect") (TSX-V:ID) (OTCQB:IDTLF) (Frankfurt:8ID), a trusted leading provider of SaaS email security today announced another month...
Spark Therapeutics to Participate in Multiple Conferences in September
Aug 30, 2017 11:30 am UTC| Business
PHILADELPHIA, Aug. 30, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that company management will...
Flexion Therapeutics to Present at the 2017 Wells Fargo Healthcare Conference
Aug 30, 2017 11:30 am UTC| Business
BURLINGTON, Mass., Aug. 30, 2017 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the...
Neos Therapeutics to Participate in Three September Conferences
Aug 30, 2017 11:30 am UTC| Business
DALLAS and FORT WORTH, Texas, Aug. 30, 2017 -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its...
Immunovaccine to Present at 19th Annual Rodman & Renshaw Global Investment Conference
Aug 30, 2017 11:05 am UTC| Business
HALIFAX, Nova Scotia, Aug. 30, 2017 -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced it will present at the 19th Annual Rodman Renshaw Global Investment...
Myriad Genetics to Present at the 2017 Morgan Stanley Global Healthcare Conference
Aug 30, 2017 11:05 am UTC| Business
SALT LAKE CITY, Aug. 30, 2017 -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the...
Aug 30, 2017 11:01 am UTC| Business
Geneva, Switzerland and Boston, MA - 30 August, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that...